Revenue (Quarterly) Chart

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.876M
March 31, 2026 1.299M
December 31, 2025 1.480M
September 30, 2025 1.568M
June 30, 2025 1.700M
March 31, 2025 1.110M
December 31, 2024 1.129M
September 30, 2024 0.8313M
June 30, 2024 1.502M
March 31, 2024 0.7648M
December 31, 2023 0.3403M
September 30, 2023 0.3558M
June 30, 2023 0.2517M
March 31, 2023 0.1254M
December 31, 2022 0.1496M
September 30, 2022 0.1013M
June 30, 2022 0.1271M
March 31, 2022 0.1323M
December 31, 2021 0.1726M
September 30, 2021 0.1947M
June 30, 2021 0.1055M
March 31, 2021 0.1088M
December 31, 2020 0.1113M
September 30, 2020 0.1086M
June 30, 2020 0.1033M
Date Value
March 31, 2020 0.0526M
December 31, 2019 0.0256M
September 30, 2019 1.410M
June 30, 2019 0.8827M
March 31, 2019 0.686M
December 31, 2018 2.959M
September 30, 2018 0.9001M
June 30, 2018 0.9366M
March 31, 2018 0.6812M
December 31, 2017 0.973M
September 30, 2017 0.776M
June 30, 2017 0.7732M
March 31, 2017 0.7335M
December 31, 2016 2.356M
September 30, 2016 0.8454M
June 30, 2016 0.8024M
March 31, 2016 0.7223M
December 31, 2015 0.9064M
September 30, 2015 0.6536M
June 30, 2015 1.304M
March 31, 2015 0.6874M
December 31, 2014 5.488M
September 30, 2014 1.032M
June 30, 2014 0.899M
March 31, 2014 0.805M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 20.10M
Healios KK 0.0439M
GNI Group Ltd. 40.23M
Agenus, Inc. 34.52M
Amgen, Inc. 10.07B